Adial Pharmaceuticals, Inc. (ADIL) NASDAQ
2.36
-0.09(-3.67%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.68M |
| Enterprise Value | -2.2M |
| P/E Ratio | -0.42 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.31 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.49 |
| Return On Equity | -1.63 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.8M |
| Net Income | -7.98M |
| Diluted EPS | -11.93 |
Balance Sheet
| Total Cash | 4.58M |
| Total Cash/Share | 3.35 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.18 |
| Book Value Per Share | 2.71 |
Price History
| 52-Week Change | -86.51 |
| 52-Week High | 19 |
| 52-Week Low | 1.31 |
| Moving Average 50 Days | 1.73 |
| Moving Average 200 Days | 5.51 |
Statistics
| Average Volume | 155,200 |
| Shares Outstanding | 959,644 |
| % Held by Institutions | 3.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | February 06, 2026 |
